Ad is loading...
PTTEX
Price
$77.24
Change
-$1.94 (-2.45%)
Updated
Nov 15 closing price
VITAX
Price
$308.76
Change
-$7.56 (-2.39%)
Updated
Nov 15 closing price
Ad is loading...

PTTEX vs VITAX

Header iconPTTEX vs VITAX Comparison
Open Charts PTTEX vs VITAXBanner chart's image
Putnam Global Technology R6
Price$77.24
Change-$1.94 (-2.45%)
VolumeN/A
CapitalizationN/A
Vanguard Information Technology Idx Adm
Price$308.76
Change-$7.56 (-2.39%)
VolumeN/A
CapitalizationN/A
PTTEX vs VITAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PTTEX vs. VITAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTTEX is a StrongSell and VITAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VITAX has more cash in the bank: 90.4B vs. PTTEX (1.34B). VITAX pays higher dividends than PTTEX: VITAX (0.69) vs PTTEX (0.58). PTTEX was incepted earlier than VITAX: PTTEX (6 years) vs VITAX (21 years). PTTEX is a more actively managed with annual turnover of: 57.00 vs. VITAX (15.00). PTTEX has a lower initial minimum investment than VITAX: PTTEX (0) vs VITAX (100000). PTTEX (32.96) and VITAX (32.50) have marching annual gain over last year. VITAX return over 5 years is better than : 158.67 vs. PTTEX (91.83).
PTTEXVITAXPTTEX / VITAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years21 years-
Gain YTD27.01924.779109%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.34B90.4B1%
Annual Yield % from dividends0.580.6984%
Returns for 1 year32.9632.50101%
Returns for 3 years1.9333.156%
Returns for 5 years91.83158.6758%
Returns for 10 yearsN/A483.34-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MYE11.70-0.03
-0.26%
Myers Industries
EXPE181.35-0.91
-0.50%
Expedia Group
ATS28.14-0.62
-2.16%
ATS Corp
INBX13.83-0.50
-3.49%
Inhibrx Biosciences Inc.
NERV2.20-0.12
-5.17%
Minerva Neurosciences